Forrester analyst, Chloe Stromberg, is hosting what looks like an interesting teleconference about Social Networking impacts on Life Sciences firms. See below for more details or click here to enroll.
Description
Like it or not, social media is coming to the life sciences industry. If you don’t believe us, check out the YouTube video of a purported Eli Lilly sales rep dishing Zyprexa’s side effects or read the passionate consumer comments on GSK’s AlliConnect blog. Harnessing social media promises big benefits to life sciences firms, like improving consumer trust in brands, but it also brings with it formidable risks, like what to do with reports of adverse drug events in forums or blogs. To navigate the unknown waters of social media safely, life sciences firms must take four steps: 1) educate executives and legal about social media ethos and adoption; 2) identify internal innovators and existing learning; 3) build a task force to draft guidelines and coordinate pilots; and 4) envision organizational change and internal resource demands to arrive at a sensible phase-one strategy.
Agenda
- Key benefits of harnessing Social Computing.
- Top risks Social Computing innovators face.
- Four steps that lead to a sensible Social Computing strategy.
- Why collaboration will accelerate learning and minimize costs.
Look forward to call.
2 comments ↓
Social networking today is unlike what traditional science exhibitions/events provides. There are little checks and balances. Veracity will take a seat behind self-service. Intermingling salesmanship with rigorous attention to accuracy… ah, here lies the issue. Many more, come to think about it. Interesting and timely topic!
John,
Thanks for the comment.
Blake
Leave a Comment